Loading…
The Effects of Angiotensin II and Specific Angiotensin Receptor Blockers on Embryonic Cardiac Development and Looping Patterns
The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used RT–PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors in embryonic day 10.25 Sprague–Dawley rats, and have used confocal...
Saved in:
Published in: | Developmental biology 1997-12, Vol.192 (2), p.572-584 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c445t-f88987d02d97e35c9b54dac169c24660c438cae27f04bdb9ebaa59040ede37393 |
---|---|
cites | cdi_FETCH-LOGICAL-c445t-f88987d02d97e35c9b54dac169c24660c438cae27f04bdb9ebaa59040ede37393 |
container_end_page | 584 |
container_issue | 2 |
container_start_page | 572 |
container_title | Developmental biology |
container_volume | 192 |
creator | Price, R.L. Carver, W. Simpson, D.G. Fu, L. Zhao, J. Borg, T.K. Terracio, L. |
description | The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used RT–PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors in embryonic day 10.25 Sprague–Dawley rats, and have used confocal microscopy to localize the AT1 receptor to the greater curvature of the developing ventricle in these animals at embryonic days (ED) 9.25 and 10.25. The antibodies used in immunolocalization studies did not distinguish between the AT1a and AT1b receptor subtypes. In whole embryo culture, Ang II added to the culture media resulted in increased ventricular growth and myocyte hypertrophy when treated embryos were compared to cultured littermate controls. Use of Losartan and PD123,319 to block the Ang II AT1 and AT2 receptors resulted in reduced ventricular development and cardiac dilation when compared to control and Ang II-treated embryos. Addition of Ang II and PD123,319 to the culture media also resulted in cardiac loop inversions which may be associated with disruption of normal myofibrillar development. These results clearly indicate an important role for Ang II in the early embryonic development of the heart. |
doi_str_mv | 10.1006/dbio.1997.8764 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_dbio_1997_8764</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012160697987649</els_id><sourcerecordid>9441690</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-f88987d02d97e35c9b54dac169c24660c438cae27f04bdb9ebaa59040ede37393</originalsourceid><addsrcrecordid>eNp1kLtOwzAUhi0EKuWysiH5BRJOEufisZQClSqBoEhskWOfFENjR3ao1IVnJ6EVEgPTGf6L_vMRchFBGAFkV6rSNow4z8Miz9gBGUfA0yDN2OshGQNEcRBlkB2TE-_fASApimRERpyxKOMwJl_LN6SzukbZeWprOjErbTs0Xhs6n1NhFH1uUepayz_aE0psO-vo9drKD3R92NBZU7mtNb11KpzSQtIb3ODatg2a7qdrYW2rzYo-iq5DZ_wZOarF2uP5_p6Sl9vZcnofLB7u5tPJIpCMpV1QFwUvcgWx4jkmqeRVypSQ_QsyZlkGkiWFFBjnNbBKVRwrIVIODFBhkic8OSXhrlc6673DumydboTblhGUA8dy4FgOHMuBYx-43AXaz6pB9Wvfg-v1Yqdjv3qj0ZVeajQSlXY9y1JZ_V_1Nz_Yg8c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Effects of Angiotensin II and Specific Angiotensin Receptor Blockers on Embryonic Cardiac Development and Looping Patterns</title><source>ScienceDirect Freedom Collection</source><creator>Price, R.L. ; Carver, W. ; Simpson, D.G. ; Fu, L. ; Zhao, J. ; Borg, T.K. ; Terracio, L.</creator><creatorcontrib>Price, R.L. ; Carver, W. ; Simpson, D.G. ; Fu, L. ; Zhao, J. ; Borg, T.K. ; Terracio, L.</creatorcontrib><description>The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used RT–PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors in embryonic day 10.25 Sprague–Dawley rats, and have used confocal microscopy to localize the AT1 receptor to the greater curvature of the developing ventricle in these animals at embryonic days (ED) 9.25 and 10.25. The antibodies used in immunolocalization studies did not distinguish between the AT1a and AT1b receptor subtypes. In whole embryo culture, Ang II added to the culture media resulted in increased ventricular growth and myocyte hypertrophy when treated embryos were compared to cultured littermate controls. Use of Losartan and PD123,319 to block the Ang II AT1 and AT2 receptors resulted in reduced ventricular development and cardiac dilation when compared to control and Ang II-treated embryos. Addition of Ang II and PD123,319 to the culture media also resulted in cardiac loop inversions which may be associated with disruption of normal myofibrillar development. These results clearly indicate an important role for Ang II in the early embryonic development of the heart.</description><identifier>ISSN: 0012-1606</identifier><identifier>EISSN: 1095-564X</identifier><identifier>DOI: 10.1006/dbio.1997.8764</identifier><identifier>PMID: 9441690</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Actins - analysis ; Angiotensin II - pharmacology ; Angiotensin II - physiology ; Angiotensin Receptor Antagonists ; Animals ; Cardiomegaly - chemically induced ; Fetal Heart - abnormalities ; Fetal Heart - drug effects ; Fetal Heart - ultrastructure ; Fibroblasts - pathology ; Heart Ventricles - drug effects ; Heart Ventricles - embryology ; Hypertrophy ; Imidazoles - pharmacology ; Imidazoles - toxicity ; Losartan - pharmacology ; Losartan - toxicity ; Morphogenesis - drug effects ; Myocardium - pathology ; Myosin Heavy Chains - analysis ; Organ Culture Techniques ; Pyridines - pharmacology ; Pyridines - toxicity ; Rats ; Rats, Sprague-Dawley ; Receptor, Angiotensin, Type 1 ; Receptor, Angiotensin, Type 2 ; Receptors, Angiotensin - physiology</subject><ispartof>Developmental biology, 1997-12, Vol.192 (2), p.572-584</ispartof><rights>1997 Academic Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-f88987d02d97e35c9b54dac169c24660c438cae27f04bdb9ebaa59040ede37393</citedby><cites>FETCH-LOGICAL-c445t-f88987d02d97e35c9b54dac169c24660c438cae27f04bdb9ebaa59040ede37393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9441690$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Price, R.L.</creatorcontrib><creatorcontrib>Carver, W.</creatorcontrib><creatorcontrib>Simpson, D.G.</creatorcontrib><creatorcontrib>Fu, L.</creatorcontrib><creatorcontrib>Zhao, J.</creatorcontrib><creatorcontrib>Borg, T.K.</creatorcontrib><creatorcontrib>Terracio, L.</creatorcontrib><title>The Effects of Angiotensin II and Specific Angiotensin Receptor Blockers on Embryonic Cardiac Development and Looping Patterns</title><title>Developmental biology</title><addtitle>Dev Biol</addtitle><description>The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used RT–PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors in embryonic day 10.25 Sprague–Dawley rats, and have used confocal microscopy to localize the AT1 receptor to the greater curvature of the developing ventricle in these animals at embryonic days (ED) 9.25 and 10.25. The antibodies used in immunolocalization studies did not distinguish between the AT1a and AT1b receptor subtypes. In whole embryo culture, Ang II added to the culture media resulted in increased ventricular growth and myocyte hypertrophy when treated embryos were compared to cultured littermate controls. Use of Losartan and PD123,319 to block the Ang II AT1 and AT2 receptors resulted in reduced ventricular development and cardiac dilation when compared to control and Ang II-treated embryos. Addition of Ang II and PD123,319 to the culture media also resulted in cardiac loop inversions which may be associated with disruption of normal myofibrillar development. These results clearly indicate an important role for Ang II in the early embryonic development of the heart.</description><subject>Actins - analysis</subject><subject>Angiotensin II - pharmacology</subject><subject>Angiotensin II - physiology</subject><subject>Angiotensin Receptor Antagonists</subject><subject>Animals</subject><subject>Cardiomegaly - chemically induced</subject><subject>Fetal Heart - abnormalities</subject><subject>Fetal Heart - drug effects</subject><subject>Fetal Heart - ultrastructure</subject><subject>Fibroblasts - pathology</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - embryology</subject><subject>Hypertrophy</subject><subject>Imidazoles - pharmacology</subject><subject>Imidazoles - toxicity</subject><subject>Losartan - pharmacology</subject><subject>Losartan - toxicity</subject><subject>Morphogenesis - drug effects</subject><subject>Myocardium - pathology</subject><subject>Myosin Heavy Chains - analysis</subject><subject>Organ Culture Techniques</subject><subject>Pyridines - pharmacology</subject><subject>Pyridines - toxicity</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Angiotensin, Type 1</subject><subject>Receptor, Angiotensin, Type 2</subject><subject>Receptors, Angiotensin - physiology</subject><issn>0012-1606</issn><issn>1095-564X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp1kLtOwzAUhi0EKuWysiH5BRJOEufisZQClSqBoEhskWOfFENjR3ao1IVnJ6EVEgPTGf6L_vMRchFBGAFkV6rSNow4z8Miz9gBGUfA0yDN2OshGQNEcRBlkB2TE-_fASApimRERpyxKOMwJl_LN6SzukbZeWprOjErbTs0Xhs6n1NhFH1uUepayz_aE0psO-vo9drKD3R92NBZU7mtNb11KpzSQtIb3ODatg2a7qdrYW2rzYo-iq5DZ_wZOarF2uP5_p6Sl9vZcnofLB7u5tPJIpCMpV1QFwUvcgWx4jkmqeRVypSQ_QsyZlkGkiWFFBjnNbBKVRwrIVIODFBhkic8OSXhrlc6673DumydboTblhGUA8dy4FgOHMuBYx-43AXaz6pB9Wvfg-v1Yqdjv3qj0ZVeajQSlXY9y1JZ_V_1Nz_Yg8c</recordid><startdate>19971215</startdate><enddate>19971215</enddate><creator>Price, R.L.</creator><creator>Carver, W.</creator><creator>Simpson, D.G.</creator><creator>Fu, L.</creator><creator>Zhao, J.</creator><creator>Borg, T.K.</creator><creator>Terracio, L.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19971215</creationdate><title>The Effects of Angiotensin II and Specific Angiotensin Receptor Blockers on Embryonic Cardiac Development and Looping Patterns</title><author>Price, R.L. ; Carver, W. ; Simpson, D.G. ; Fu, L. ; Zhao, J. ; Borg, T.K. ; Terracio, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-f88987d02d97e35c9b54dac169c24660c438cae27f04bdb9ebaa59040ede37393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Actins - analysis</topic><topic>Angiotensin II - pharmacology</topic><topic>Angiotensin II - physiology</topic><topic>Angiotensin Receptor Antagonists</topic><topic>Animals</topic><topic>Cardiomegaly - chemically induced</topic><topic>Fetal Heart - abnormalities</topic><topic>Fetal Heart - drug effects</topic><topic>Fetal Heart - ultrastructure</topic><topic>Fibroblasts - pathology</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - embryology</topic><topic>Hypertrophy</topic><topic>Imidazoles - pharmacology</topic><topic>Imidazoles - toxicity</topic><topic>Losartan - pharmacology</topic><topic>Losartan - toxicity</topic><topic>Morphogenesis - drug effects</topic><topic>Myocardium - pathology</topic><topic>Myosin Heavy Chains - analysis</topic><topic>Organ Culture Techniques</topic><topic>Pyridines - pharmacology</topic><topic>Pyridines - toxicity</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Angiotensin, Type 1</topic><topic>Receptor, Angiotensin, Type 2</topic><topic>Receptors, Angiotensin - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Price, R.L.</creatorcontrib><creatorcontrib>Carver, W.</creatorcontrib><creatorcontrib>Simpson, D.G.</creatorcontrib><creatorcontrib>Fu, L.</creatorcontrib><creatorcontrib>Zhao, J.</creatorcontrib><creatorcontrib>Borg, T.K.</creatorcontrib><creatorcontrib>Terracio, L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Developmental biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Price, R.L.</au><au>Carver, W.</au><au>Simpson, D.G.</au><au>Fu, L.</au><au>Zhao, J.</au><au>Borg, T.K.</au><au>Terracio, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effects of Angiotensin II and Specific Angiotensin Receptor Blockers on Embryonic Cardiac Development and Looping Patterns</atitle><jtitle>Developmental biology</jtitle><addtitle>Dev Biol</addtitle><date>1997-12-15</date><risdate>1997</risdate><volume>192</volume><issue>2</issue><spage>572</spage><epage>584</epage><pages>572-584</pages><issn>0012-1606</issn><eissn>1095-564X</eissn><abstract>The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used RT–PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors in embryonic day 10.25 Sprague–Dawley rats, and have used confocal microscopy to localize the AT1 receptor to the greater curvature of the developing ventricle in these animals at embryonic days (ED) 9.25 and 10.25. The antibodies used in immunolocalization studies did not distinguish between the AT1a and AT1b receptor subtypes. In whole embryo culture, Ang II added to the culture media resulted in increased ventricular growth and myocyte hypertrophy when treated embryos were compared to cultured littermate controls. Use of Losartan and PD123,319 to block the Ang II AT1 and AT2 receptors resulted in reduced ventricular development and cardiac dilation when compared to control and Ang II-treated embryos. Addition of Ang II and PD123,319 to the culture media also resulted in cardiac loop inversions which may be associated with disruption of normal myofibrillar development. These results clearly indicate an important role for Ang II in the early embryonic development of the heart.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>9441690</pmid><doi>10.1006/dbio.1997.8764</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-1606 |
ispartof | Developmental biology, 1997-12, Vol.192 (2), p.572-584 |
issn | 0012-1606 1095-564X |
language | eng |
recordid | cdi_crossref_primary_10_1006_dbio_1997_8764 |
source | ScienceDirect Freedom Collection |
subjects | Actins - analysis Angiotensin II - pharmacology Angiotensin II - physiology Angiotensin Receptor Antagonists Animals Cardiomegaly - chemically induced Fetal Heart - abnormalities Fetal Heart - drug effects Fetal Heart - ultrastructure Fibroblasts - pathology Heart Ventricles - drug effects Heart Ventricles - embryology Hypertrophy Imidazoles - pharmacology Imidazoles - toxicity Losartan - pharmacology Losartan - toxicity Morphogenesis - drug effects Myocardium - pathology Myosin Heavy Chains - analysis Organ Culture Techniques Pyridines - pharmacology Pyridines - toxicity Rats Rats, Sprague-Dawley Receptor, Angiotensin, Type 1 Receptor, Angiotensin, Type 2 Receptors, Angiotensin - physiology |
title | The Effects of Angiotensin II and Specific Angiotensin Receptor Blockers on Embryonic Cardiac Development and Looping Patterns |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A30%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effects%20of%20Angiotensin%20II%20and%20Specific%20Angiotensin%20Receptor%20Blockers%20on%20Embryonic%20Cardiac%20Development%20and%20Looping%20Patterns&rft.jtitle=Developmental%20biology&rft.au=Price,%20R.L.&rft.date=1997-12-15&rft.volume=192&rft.issue=2&rft.spage=572&rft.epage=584&rft.pages=572-584&rft.issn=0012-1606&rft.eissn=1095-564X&rft_id=info:doi/10.1006/dbio.1997.8764&rft_dat=%3Cpubmed_cross%3E9441690%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-f88987d02d97e35c9b54dac169c24660c438cae27f04bdb9ebaa59040ede37393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/9441690&rfr_iscdi=true |